Weekly Briefing: Control Over Capability — M&A, AI Infrastructure, and the New Logic of Strategic Scale

Week of May 18, 2026 | Limited Liability Solutions Strategic Advisory

This Week at a Glance

Global deal activity remained robust and strategically purposeful this week, with transaction volumes concentrated in healthcare, AI-enabled services, energy infrastructure, and consumer goods — sectors where acquirers are competing for scarce, defensible assets rather than speculative growth. Headline transactions exceeded $28 billion in aggregate announced value, reflecting continued confidence in strategic M&A where asset quality and integration logic are clear. The overarching theme for corporate decision-makers is unambiguous: scale, operational resilience, and direct control over critical capabilities — compute, energy, talent, and pipeline — are now the primary drivers of deal rationale.

M&A Activity: Large-Cap Consolidation Across Sectors

  • Merck Sharp & Dohme / Verona Pharma ($10.0bn): The week’s largest transaction underscores Big Pharma’s sustained appetite for commercial-stage and late-pipeline assets. With organic R&D timelines under pressure, acquirers are paying premium multiples for de-risked assets with near-term revenue visibility. Boards and CFOs in the life sciences space should expect continued compression of available targets and upward pressure on valuation benchmarks.
  • CoreWeave / Core Scientific ($9.0bn): This transaction is among the most structurally significant of the week. CoreWeave’s move to acquire Core Scientific consolidates AI compute capacity with physical data centre infrastructure, signalling that hyperscale AI operators are moving beyond leasing arrangements toward owned, controlled infrastructure stacks. The deal reflects a broader shift in how AI-native businesses think about capital allocation and competitive moat.
  • Royal Gold / Sandstorm Gold ($3.5bn) and Ferrero / WK Kellogg ($3.1bn): Cross-sector consolidation continued in commodities royalties and branded consumer goods, reinforcing that the M&A impulse is not confined to technology. In both cases, the acquirer is securing either cash-generative royalty streams or established distribution and brand infrastructure — assets that are difficult to replicate organically and increasingly valued for their resilience characteristics.

Digital Transformation & AI: From Experimentation to Operational Integration

  • Capgemini / WNS ($3.3bn): This acquisition is a defining signal for the enterprise technology services market. Capgemini is acquiring WNS to accelerate its intelligent operations and agentic AI capabilities, particularly for U.S.-based clients. The transaction reflects a maturation in enterprise AI adoption: buyers are no longer funding pilots — they are acquiring scaled delivery platforms that can embed AI into core client workflows and generate measurable margin leverage.
  • Infrastructure as strategic asset: The CoreWeave-Core Scientific combination reinforces a theme that has been building for several quarters — physical AI infrastructure (data centres, power capacity, cooling systems) is now as strategically contested as software IP. For General Counsel and CFOs evaluating technology partnerships or vendor dependencies, this consolidation trend warrants a structural review of counterparty concentration risk.
  • Agentic AI and service delivery transformation: The broader deal narrative this week points to acquirers seeking capabilities that are immediately deployable at scale. Boards overseeing digital transformation programmes should assess whether their current vendor and partner ecosystem is structurally stable in light of accelerating consolidation among tier-one technology service providers.

Regulatory & Compliance: Cross-Border Execution Risk Remains Elevated

  • Data governance in AI-enabled transactions: While no major GDPR enforcement actions were reported this week, the volume of data-intensive acquisitions — particularly in AI services and business process outsourcing — elevates compliance obligations for European acquirers and targets. Early-stage data mapping, jurisdictional analysis, and privacy impact assessments are no longer optional steps in due diligence; they are threshold conditions for regulatory approval in several EU member states.
  • Competition scrutiny on scale transactions: The concentration of deal activity in sectors already subject to heightened antitrust attention — healthcare, digital infrastructure, financial services — increases the probability of extended regulatory review timelines. CFOs and General Counsel should build material regulatory risk buffers into deal timetables and financing structures, particularly for transactions with significant EU or UK market presence.
  • Foreign investment screening: Cross-border transactions involving energy assets, compute infrastructure, or sensitive data continue to attract national security review under CFIUS, the UK NSI Act, and equivalent European regimes. Early engagement with advisors on screening obligations remains a prerequisite for transactions in these sectors.

Capital Markets & Finance: Selective Deployment Into Resilient Assets

  • Financing conditions remain supportive: The volume and scale of announced transactions this week suggest that debt and equity capital markets continue to support well-structured strategic M&A. Acquirers with strong balance sheets and clear integration narratives are accessing financing at terms that reflect asset quality rather than macro caution.
  • Premium valuations for scarcity assets: Across healthcare pipeline, royalty streams, AI infrastructure, and branded consumer goods, this week’s transactions confirm that the market is pricing scarcity and defensibility at a significant premium. CFOs evaluating portfolio composition should consider whether their own assets are positioned to attract or command similar recognition.
  • Capital allocation discipline: The common thread across the week’s largest transactions is selectivity — acquirers are not pursuing growth at any price, but are deploying capital into assets that offer either strategic control, cash generation, or both. This discipline is a meaningful signal for boards reviewing capital allocation frameworks and long-range planning assumptions.

Geopolitics & Trade: Strategic Inputs Under Competitive Pressure

  • Energy and compute as geopolitical assets: The convergence of energy security concerns and AI infrastructure investment is reshaping how governments and corporates think about strategic inputs. Transactions involving power generation capacity, data centre real estate, and compute infrastructure are increasingly evaluated through a national interest lens, with implications for deal structure, ownership thresholds, and operational commitments.
  • European exposure to cross-border execution risk: For European corporates pursuing outbound M&A — particularly into the United States or across emerging market jurisdictions — the current geopolitical environment demands a more rigorous pre-signing assessment of regulatory, trade, and political risk. Industrial policy shifts in major economies continue to alter the conditions under which cross-border transactions can be completed and operated.

What to Watch

  • Regulatory filings on large-cap healthcare and AI transactions: The Merck / Verona and Capgemini / WNS transactions will move into formal regulatory review in the coming weeks. The pace and conditions of approval will be an important indicator of the current antitrust and foreign investment climate for similarly structured deals.
  • Secondary consolidation in AI infrastructure: Following CoreWeave’s move on Core Scientific, watch for further M&A activity among data centre operators, power utilities with co-location capacity, and compute hardware providers. The race to control physical AI infrastructure is accelerating, and secondary assets will attract attention from both strategic and financial buyers.
  • Capital markets conditions into Q3 2026: With a substantial pipeline of announced but unclosed transactions, the stability of financing markets through the summer will be a key variable. Any material shift in credit spreads or equity market sentiment could affect deal timing, financing structures, and the appetite for new announcements.

LLS Perspective

This week’s transaction landscape offers a clear and consistent message for executive leadership: the logic of strategic M&A has shifted from growth optionality to capability control. Acquirers across healthcare, technology services, energy, and consumer goods are not buying market share in the traditional sense — they are securing direct ownership of the inputs, platforms, and infrastructure that will determine competitive position over the next decade. For CFOs, this has immediate implications for how capital allocation frameworks are constructed and communicated to boards and investors. For General Counsel, the convergence of AI, data, and cross-border execution in a single transaction environment demands earlier and more integrated legal and regulatory engagement than deal teams have historically prioritised. At Limited Liability Solutions, we advise clients that the most significant risk in the current environment is not overpaying for the right asset — it is underinvesting in the preparation, structuring, and governance required to close and integrate it effectively. Boards that treat M&A readiness as a continuous organisational capability, rather than a transaction-by-transaction exercise, will be materially better positioned to act when the right opportunity presents itself.